Module Title
Clinical Pharmacology And Therapeutics 1
Keywords
pharmacology, pharmacokinetics,evidence-based therapeutics, pathophysiology, psychiatry, cardiovascular system, endocrine system, nervous system and urinary system. |
|
Prerequisites for Module
Successful completion of module PH 2021 or its equivalent.
Corequisite Modules
None.
Precluded Modules
None.
Aims of Module
To provide the student with a knowledge and understanding of the principles and concepts of pathophysiology, pharmacology, pharmacokinetics, evidence-based therapeutics and the ability to apply these to selected body systems.
Learning Outcomes for Module
On completion of this module, students are expected to be able to:
| 1. |
recognise and explain fundamentals of pharmacology, pharmacokinetics and evidence-based therapeutics and describe the pathophysiology, aetiology, epidemiology and clinical manifestations of commonly occuring disease states.
|
| 2. |
utilise knowledge and understanding from learning outcome 1 to identify pharmacological/ pharmacokinetic and therapeutic issues and justify suitable evidence based therapeutic strategies.
|
| 3. |
retrieve, evaluate, manipulate, interpret and present experimental/ clinical data and information.
|
| 4. |
work effectively as a member of a team to communicate and defend therapeutic plans.
|
| 5. |
demonstrate competence in pharmacokinetic calculations.
|
Indicative Module Content
Pharmacology: drug/receptor theory; mechanism of drug action; principles of pharmacodynamics and pharmacokinetics.
Pathophysiology, pharmacology, and evidence-based therapeutics of psychiatry, nervous,endocrine, cardiovascular and urinary systems. Evidence-based therapeutics to include setting goals of therapy; drug selection; adverse drug reactions; new therapies, monitoring and counselling.
Indicative Student Workload
Contact Hours
| Full Time | Assessment
| 3 | Coursework
| 59 | Lectures
| 51 | Tutorial
| 6 |
Directed Study
| |
| 195 |
Private Study
| |
| 136 |
| Mode of Delivery
Lectures, coursework sessions, which include: individual and group problem solving exercises; tutorial sessions; CAL materials. Directed study includes: computer packages; directed reading and self-assessment exercises.
Assessment Plan
|
Learning Outcomes Assessed
| | Component 1 | 1,2
| | Component 2 | 3,4,5
|
Component 2 is a portfolio of coursework assessments.It will comprise of a MCQ test in pharmacology and kinetics at the end of semester 1, contributing 15% to Module grade and a group presentation in semester 2 based on a case study, contributing 15% to Module grade. The mark for the presentation will include an element of peer assessment. The coursework contributes 30% towards final Module grade.
Component 1 is a 2 hour written examination.It will consist of multiple-choice, short answer and essay type questions. The examination contributes 70% towards the final Module Grade.
Indicative Bibliography
| 1. | BORON, W.F. AND BOULPAEP, E.L. Medical Physiology. (current edition). Philadelphia: Saunders Elsevier Science.
| | 2. | MINNEMAN, K, WECKER,L, Brody's Human Pharmacology.(current edition).Philadelphia: Saunders Elsevier Mosby.
| | 3. | *RANG, H.P., DALE, M.M. AND RITTER, J.M. Pharmacology. (current edition). Edinburgh: Churchill Livingstone.
| | 4. | *WALKER, R. AND EDWARDS, C.Clinical Pharmacy and Therapeutics. (current edition). Edinburgh: Churchill Livingstone.
|
Additional Notes
* recommended purchase
|
|